comparemela.com

Latest Breaking News On - Anne prener - Page 1 : comparemela.com

Positive Results for Patients with Non-obstructive Hypertrophic Cardiomyopathy Treated with

– Improvements in both patient-reported symptoms of heart failure and ventilatory efficiency during exercise testing were demonstrated –

United statesMartins maronAnne prenerKomal joshiImbria pharmaceuticalsJournal of the american college cardiologyHypertrophic cardiomyopathy center at lahey hospitalImbria pharmaceuticals incAmerican collegeAnnual scientific sessionHypertrophic cardiomyopathy centerLahey hospitalMedical centerJai patelKey resultsPrimary endpoint

Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction

Phase 2 trials underway with ninerafaxstat in three cardiovascular indications; multiple data read-outs expected in 2023

Anne prenerImbria pharmaceuticals incImbria pharmaceuticalsJai patel

Rubius Therapeutics : Appoints Susanne Schaffert, Ph D , to its Board of Directors - Form 8-K

Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors CAMBRIDGE, Mass., July 14, 2022 - Rubius Therapeutics, Inc. , a clinical-stage. | July 14, 2022

Rhode islandUnited statesUnited kingdomLori murrayPabloj cagnoniSusanne schaffertAnne prenerGlobal novartis oncology leadership teamExchange commissionRubius therapeutics incUniversity of erlangen germanyBoston globeCorporate affairsRubius therapeutics appoints susanne schaffertRed cell therapeuticsNovarti oncology business

Rubius Therapeutics (RUBY) Appoints Susanne Schaffert to its Board

Rubius Therapeutics (RUBY) Appoints Susanne Schaffert to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pabloj cagnoniSusanne schaffertAnne prenerRubius therapeutics incUniversity of erlangen germanyGlobal novartis oncology leadership teamRed cell therapeuticsNovarti oncology businessRegion headNovartis oncology europeAccelerated advanced applicationsInvestor relationsGlobal franchise headNovartis germanyNorganic chemistry

Rubius Therapeutics Appoints Susanne Schaffert, Ph D , to its Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Rhode islandUnited statesUnited kingdomMarissa hanifyLori murrayPabloj cagnoniSusanne schaffertAnne prenerGlobal novartis oncology leadership teamExchange commissionRubius therapeutics incUniversity of erlangen germanyCorporate communicationsBoston globeCorporate affairsRed cell therapeutics

vimarsana © 2020. All Rights Reserved.